<DOC>
	<DOCNO>NCT02218385</DOCNO>
	<brief_summary>The purpose study measure performance characteristic collection , fixation transportation clinical nipple aspirate fluid ( NAF ) specimens ForeCYTE Breast Aspirator across 3 independent labs National Reference Laboratory Breast Health ( NRLBH ) . The study hypothesis lab specimen acceptability rate least 90 % . If assume true level acceptability test approximately 96 % , low bound one-sided 95 % confidence interval expect least 90 % .</brief_summary>
	<brief_title>ForeCYTE Breast Aspirator Sample Collection Cytological Testing Nipple Aspirate Fluid</brief_title>
	<detailed_description>A ) NAF Collection physician 's office : The Principle Investigator identify qualified study subject . He assign study coordinator clinic complete entry Study Case Report Form relate collection site . He collect NAF specimen Physician Office Collection Sites accordance Instructions Use . B ) NAF Processing physician 's office : The Principle Investigator 's designate process NAF specimen shipment select laboratory accordance Instructions Use . C ) NAF Transport physician 's office laboratory : The patient specimen collection membrane place resealable pouch , pack shipping box ( provide ) transport Federal Express participate Independent Clinical Laboratories . The Federal Express package pre-labeled PI within four laboratory specimens sent order collect laboratory . Left right breast specimen subject send lab , subject base sequence . The shipment ship serially lab ABCD , ABCD , ABCD , ABCD , etc . So specimens subject 1 go laboratory A , specimens subject 2 lab B , specimens subject 3 lab C , specimens subject 4 lab D , specimens subject 5 lab A , etc . The PI complete Testing Facility Shipping Receiving Tracking Form specimens . D ) NAF Processing laboratory : The NAF process clinical cytology laboratory accordance Instructions Use accompany patient kit . E ) NAF Cytology Classification : A trained , board-certified pathologist read slide . The data report Case Report Form accord format recommend College American Pathologists . The criterion read interpret slide contain Table 2 adapt King , et al . The laboratory portion Case Report Form complete patient .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Healthy , female , age 2075 year , bilateral specimen obtain . 2 . Any woman NAF cytology test consider beneficial physician . 3 . Nonlactating nonpregnant ( document date Last Menstrual Period postmenopausal ) . 4 . Good general health determine medical history , breast disease/cancer history , clinical breast exam . 5 . Willing give inform consent follow study procedure direct . 1 . Medical condition/psychiatric condition make subject poor candidate study , determine Principal Investigator . 2 . Pregnancy suspicion pregnancy . 3 . Open cutaneous wound atopic dermatitis area nippleareolar complex . 4 . No inverted nipple breast unfit fluid collection , significant prior surgery area nippleareolar complex . 5 . Participation investigational drug device study le 30 day prior enrollment study . 6 . Pregnancy , childbirth , lactation le 90 day prior enrollment study . 7 . Acute illness , include take antibiotic , analgesic , antipyretic and/or cold medication less 7 day prior enrollment study .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Nipple Aspirate Fluid</keyword>
	<keyword>Breast Health Screening</keyword>
	<keyword>Cytology</keyword>
</DOC>